Literature DB >> 15053872

Ubiquitin recognition by the human TSG101 protein.

Wesley I Sundquist1, Heidi L Schubert, Brian N Kelly, Gina C Hill, James M Holton, Christopher P Hill.   

Abstract

The UEV domain of the TSG101 protein functions in both HIV-1 budding and the vacuolar protein sorting (VPS) pathway, where it binds ubiquitylated proteins as they are sorted into vesicles that bud into late endosomal compartments called multivesicular bodies (MVBs). TSG101 UEV-ubiquitin interactions are therefore important for delivery of both substrates and hydrolytic enzymes to lysosomes, which receive proteins via fusion with MVBs. Here, we report the crystal structure of the TSG101 UEV domain in complex with ubiquitin at 2.0 A resolution. TSG101 UEV contacts the Ile44 surface and an adjacent loop of ubiquitin through a highly solvated interface. Mutations that disrupt the interface inhibit MVB sorting, and the structure also explains how the TSG101 UEV can independently bind its ubiquitin and Pro-Thr/Ser-Ala-Pro peptide ligands. Remarkably, comparison with mapping data from other UEV and related E2 proteins indicates that although the different E2/UEV domains share the same structure and have conserved ubiquitin binding activity, they bind through very different interfaces.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053872     DOI: 10.1016/s1097-2765(04)00129-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  88 in total

Review 1.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

2.  Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction.

Authors:  Young Jun Im; Lillian Kuo; Xuefeng Ren; Patricia V Burgos; Xue Zhi Zhao; Fa Liu; Terrence R Burke; Juan S Bonifacino; Eric O Freed; James H Hurley
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

3.  The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.

Authors:  Marc C Johnson; Jared L Spidel; Danso Ako-Adjei; John W Wills; Volker M Vogt
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Structural mechanism for ubiquitinated-cargo recognition by the Golgi-localized, gamma-ear-containing, ADP-ribosylation-factor-binding proteins.

Authors:  Gali Prag; Sangho Lee; Rafael Mattera; Cecilia N Arighi; Bridgette M Beach; Juan S Bonifacino; James H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

5.  A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties.

Authors:  Sergey Chupreta; Sam Holmstrom; Lalitha Subramanian; Jorge A Iñiguez-Lluhí
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 6.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

Authors:  Shawn S-C Li
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

7.  Structural basis for endosomal targeting by the Bro1 domain.

Authors:  Jaewon Kim; Sujatha Sitaraman; Aitor Hierro; Bridgette M Beach; Greg Odorizzi; James H Hurley
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

8.  Structural and functional organization of the ESCRT-I trafficking complex.

Authors:  Michael S Kostelansky; Ji Sun; Sangho Lee; Jaewon Kim; Rodolfo Ghirlando; Aitor Hierro; Scott D Emr; James H Hurley
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

Review 9.  Ubiquitin-binding domains - from structures to functions.

Authors:  Ivan Dikic; Soichi Wakatsuki; Kylie J Walters
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

10.  Computational identification of slow conformational fluctuations in proteins.

Authors:  Arvind Ramanathan; Pratul K Agarwal
Journal:  J Phys Chem B       Date:  2009-12-31       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.